The Vinehealth digital personalised cancer support platform maximises quality of life and clinical outcomes for cancer patients by delivering personalised cancer support at scale.<
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
